GenderGP uses a protocol-driven prescribing model shaped by effectiveness, US medical liability and pharmacy restrictions. This is because of:
- US pharmacy and telehealth rules
- Prescriber regulations
- State-level medical board standards
Because of this, we have hard maximum doses depending on the hormone and route of administration. Clinical safety standards mean that we need to prioritise well-established, evidence-based hormone regimens. By keeping the dosages to well-supported levels, we aim to provide effective, safe care across states while minimising risk both for members and clinicians.
Instead, you can:
- Switch administration route
- Change formulation
- Adjust dosing method (e.g., split dosing)